Effects of High-Flux Hemodialysis Combined with L-Carnitine on Microinflammation and Arteriovenous Fistula in Maintenance Hemodialysis Patients

The study examined the impact of high-flux hemodialysis combined with L-carnitine on microinflammation and arteriovenous fistula complications in 65 maintenance hemodialysis patients. The experimental group of 35 patients showed significant improvements in clinical efficacy, cardiac function, and quality of life compared to the control group of 30 patients, who received only high-flux hemodialysis. The combination treatment effectively reduced inflammatory markers and complications related to intravenous fistulas. Despite the positive outcomes, the study noted the small sample size and recommended further research to validate these findings.